I didn't sell any of my shares on this pop either. I had prepared myself prior to the venture announcement on what to do based on results vs tirzepatide. Please see #msg-173869018 where I commented:
My reaction to the data readout was that VK2735 was not just superior to Tirzepatide but clearly so both on efficacy and tolerability. Also- it’s likely at least equal from an efficacy standpoint to LLY’s “safety challenged” triple G Retraglutide that is still in development.
So now I think there is no question to whether VKTX as a buyout candidate will fetch an 11 figure number (as in above $10B USD) . It will. The question now is how high an 11 figure number. ( or maybe a really lucrative partnership deal may materialize because VKTX may just be too pricey?) I’m going to be posting on this when I can find time.
As to what I did the day the results on venture were announced? Well I had about 15% of my portfolio in cash looking for a good opportunity. Given the market cap of VKTX was well under where I thought it should be (or rather where I think it will go), that management was holding back important data likely to be positive (more on that later) I bought more VKTX using half of my remaining cash.
BTW- your post #msg-171506339 from last year before Viking released phase 1 results on VK2735 belongs in the Biotech Values hall of fame if there were such a thing. If I may, I’d like to comment on yesterday's VKTX price action after their successful secondary raise of $550 million.
Yesterday’s 18% fall in VKTX was the second most idiotic thing I’ve seen in my six years of following this stock.
Maybe a slight fall was in order because of the raise or maybe because the stock had some short covering but Viking is largely de-risked now:
VK2735 works and works really well in sub q form.
A bunch of smart investors just put down over a half a billion (at $85 a share) to show their conviction.
VKTX has multiple other blockbuster potential drugs/indications that minimally include Nash, X-Ald and Oral weight loss.
While VKTX is not completely de-risked (bad things could still happen), like you, I also believe acquisition is "100% inevitable." I continue to like the risk/reward Viking offers better than anything else out there.
"People are best convinced by reasons they discover themselves"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.